Annual Henry Ford Cancer Institute Multi-Disciplinary Breast Oncology Symposium

Friday, November 5, 2021, 7:30 AM - 3:35 PM, Online


AMA PRA Category 1 Credits™ (6.00 hours), Non-Physician Attendance (6.00 hours)

Exciting progress is underway regarding surgical options for the breast and axilla in neoadjuvant chemotherapy patients, lymphedema prevention. How COVID-19 has impacted screening delays and the effects of the vaccine on treatment. The evolution of the role of genomic profiling and genetic testing. Physicians involved with the diagnosis and management of breast cancer patients need to be kept apprised of new information in all of these areas.

1. Ensure physicians have a better understanding of axillary management after NAC
2. Ensure physicians are more comfortable with breast imaging after patients receive COVID-19 vaccination
3. Ensure physicians are more knowledgeable on how supportive services effect breast cancer and are better equipped to advise patients
4. Provide current screening guideline recommendations for general and high risk populations, including gadolinium concerns
5. Ensure physicians have a better understanding of the surgical prevention options for lymphedema
6. Ensure physicians have a better understanding of the role of XRT in the treatment for 1-3 positive nodes

REGISTRATION FOR THIS SYMPOSIUM AND OPEN HOUSE IS CLOSED. 

Please contact Linda Murray, at [email protected], for further information.

 

 

Henry Ford Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

DESIGNATION STATEMENT:

Henry Ford Health designates this live course for a maximum of 6.00 AMA PRA Category 1 Credit(s) TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

 

FACULTY/PLANNING COMMITTEE DISCLOSURE STATEMENT: 

 In compliance with the ACCME standards for Commercial Support, all individuals in a position to control/influence the content of this activity are required to disclose all financial interests of their own with any ACCME defined commercial interests for the past 24 months and/or non-FDA approved use of a drug or a device that is included in the presentation. All financial relationships have been mitigated prior to the commencement of the activity.

 

ACCESSIBILITY STATEMENT: 

Henry Ford Health provides qualified interpreters and other aids for Deaf, DeafBlind, and Hard-of-Hearing persons at no cost. To request assistance, contact the event coordinator: [email protected]. Please allow a minimum of 3 days to process this request.

Cancellation Policy

Please send cancellation requests to [email protected].

Henry Ford Health System Office of Continuing Medical Education reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
Henry Ford Health System Office of Continuing Medical Education is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

The Henry Ford Health System Office of Continuing Medical Education adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Henry Ford Health System adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, November 5, 2021